INTRODUCTION: ACT Lifesciences Pvt. Ltd. has been established in 2013. Following, we are active in following ➢ Scientific writing and mobile apps development: Here we have Big pharma clients like Alkem, Zuventus and MNC Abbott and MJN. ➢ Import and export of medicines: We have clients in Africa and Europe. ACT Lifesciences Pvt Ltd have grown by 100% each financial year. ACT Lifesciences proposes to backward integrate into manufacturing of Natural Extracts. The natural extract market has huge growth potential and the local fauna supports it with vide variety and also availability throughout the year. As an innovative technology differential, extraction of Natural Products shall be done using ‘Super Critical Carbon DiOxide’. Super Critical Fluid Extraction (SCFE): Any extraction process requires a Solvent which entraps the active ingredient from the solid Matrix and is than separated. Petroleum based solvents are used Conventionally eg. Ether, Ethanol, Methylene chloride, hexane. ACT proposes to use supercritical extraction in which Carbon di-oxide at critical pressure and temperature acts like solvent. High temperature, which degrades product’s quality, is avoided and no residu

Other business activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.